Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-018593
Filing Date
2025-07-10
Accepted
2025-07-10 16:17:22
Documents
1
Period of Report
2025-07-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3099
  Complete submission text file 0001641172-25-018593.txt   4557
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Issuer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 165 LUDLOW AVE. NORTHVALE NJ 07647
Business Address
Plassche Douglas (Reporting) CIK: 0001600946 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15697 | Film No.: 251116505